🔔 Get instant alerts when AUROPHARMA files quarterly results on BSE Start free trial →

Aurobindo Pharma Limited — Financials & Forensics

Sector: Healthcare · NSE: AUROPHARMA · BSE: 524804 · ISIN: INE406A01037

₹1,675.45
Closing price
11 Sep 2026
+51.1%
1-year price change
₹98,165 Cr
Market cap
28.2×
P/E ratio (trailing)
11.2%
Return on Equity (FY)
⚡ What you get within minutes of every filing
ISA
Indian Stock Alerts BOT
🚨 AUROPHARMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add AUROPHARMA to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime
AUROPHARMA price
→
Loading…
Compare with:
Loading chart…

Annual P&L snapshot

Line item FY21FY22FY23FY24FY25
Revenue from operations ₹24,775 Cr ₹23,455 Cr ₹24,855 Cr ₹29,002 Cr ₹31,724 Cr
EBITDA ₹5,333 Cr ₹4,387 Cr ₹3,719 Cr ₹5,843 Cr ₹6,583 Cr
EBITDA margin 21.5% 18.7% 15.0% 20.1% 20.8%
Profit after tax ₹5,335 Cr ₹2,648 Cr ₹1,928 Cr ₹3,173 Cr ₹3,486 Cr

Source: Aurobindo Pharma Limited's regulatory filings under SEBI LODR Regulation 33. View full financials →

Deeper analysis

🔍 Forensic red-flag screen
Automated screen across audit / governance / accruals / RPT / pledge dimensions. Score, verdict and top flagged items.
🤝 Related-party transactions
RPT volume, transaction count, materiality flag from the latest SEBI integrated filing under Regulation 23(9).

Recent filings by Aurobindo Pharma Limited

Never miss a filing again

1
Sign in with Google
2
Add stocks to watchlist
3
Get instant Telegram alerts
Get started — it's free →
14-day Pro trial included · No credit card required

About Aurobindo Pharma Limited on Indian Stock Alerts

Indian Stock Alerts tracks Aurobindo Pharma Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.

Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.

Important. All data on this page is sourced from Aurobindo Pharma Limited's own public regulatory filings under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Investors should consult registered advisers before making investment decisions.
Notice a data issue? Filings are extracted automatically and may occasionally contain parse errors. Email support@indianstockalerts.com with the URL and we'll correct within 24 hours.